GSK-3β has important roles as both a tumor suppressor (e.g., inhibition of β-catenin, c-Myc, and Mcl-1) and promoter (e.g., inhibition of the cell cycle inhibitor p27Kip1) [30]. The gene discussed is CDKN1B; the disease is neoplasm.